Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study.
- DOI
- 10.3390/vaccines10101685
- Published
- 2022 Oct 9
- Container
- Vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines10101685,
title = {Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study.},
author = {Banjongjit A and Phirom S and Phannajit J and Jantarabenjakul W and Paitoonpong L and Kittanamongkolchai W and Wattanatorn S and Prasithsirikul W and Eiam-Ong S and Avihingsanon Y and Hansasuta P and Vanichanan J and Townamchai N},
year = {2022},
journal = {Vaccines},
doi = {10.3390/vaccines10101685},
url = {https://doi.org/10.3390/vaccines10101685}
}RIS
TY - JOUR TI - Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study. AU - Banjongjit A AU - Phirom S AU - Phannajit J AU - Jantarabenjakul W AU - Paitoonpong L AU - Kittanamongkolchai W AU - Wattanatorn S AU - Prasithsirikul W AU - Eiam-Ong S AU - Avihingsanon Y AU - Hansasuta P AU - Vanichanan J AU - Townamchai N PY - 2022 JO - Vaccines DO - 10.3390/vaccines10101685 UR - https://doi.org/10.3390/vaccines10101685 ER -
APA
A, B., S, P., J, P., W, J., L, P., W, K., S, W., W, P., S, E., Y, A., P, H., J, V., & N, T. (2022). Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study.. Vaccines. https://doi.org/10.3390/vaccines10101685
Source records
- pubmed · retrieved 2026-09-26T12:53:27.609Z